АЛГОРИТМ ДИАГНОСТИКИ И ВЕДЕНИЯ ДЕВОЧЕК‑ПОДРОСТКОВ С ГЕНИТАЛЬНЫМ ЭНДОМЕТРИОЗОМ

1. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet. Gynecol. 2018; 132(6): e249‑58. https://dx.doi.org/10.1097/ AOG.0000000000002978

2. NICE. Endometriosis: diagnosis and management. NICE guideline. London: National Institute for Health and Care Excellence; 2024. 32 p. Available at: https:// www.ncbi.nlm.nih.gov/books/NBK604070/pdf/Bookshelf_NBK604070.pdf

3. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L. et al. ESHRE guideline: endometriosis. Hum. Reprod. Open. 2022; 2022(2): hoac009. https:// dx.doi.org/10.1093/hropen/hoac009

4. Yeung P. Jr., Gupta S., Gieg S. Endometriosis in adolescents: A systematic review. J. Endometr. Pelvic Pain Disord. 2017; 9(1): 17‑29. https://dx.doi.org/10.5301/ je.5000264

5. Laganà A.S., Garzon S., Götte M., Viganò P., Franchi M., Ghezzi F. et al. The Pathogenesis of endometriosis: molecular and cell biology insights. Int. J. Mol. Sci. 2019; 20(22): 5615. https://dx.doi.org/10.3390/ijms20225615

6. Lee H.C., Lin S.C., Wu M.H., Tsai S.J. Induction of pyruvate dehydrogenase kinase 1 by hypoxia alters cellular metabolism and inhibits apoptosis in endometriotic stromal cells. Reprod. Sci. 2019; 26(6): 734‑44. https://dx.doi.org/10.1177/1933719118789513

7. Kazmi I., Alharbi K.S., Al-Abbasi F.A., Almalki W.H., G S.K., Yasmeen A. et al. Role of epithelial‑to‑mesenchymal transition markers in different stages of endometriosis: Expression of the Snail, Slug, ZEB1, and Twist Genes. Crit. Rev. Eukaryot. Gene Expr. 2021; 31(2): 89‑95. https://dx.doi.org/10.1615/CritRevEuk aryotGeneExpr.2021037996

8. Khashchenko E.P., Vysokikh M.Y., Marey M.V., Sidorova K.O., Manukhova L.A., Shkavro N.N. et al. Altered glycolysis, mitochondrial biogenesis, autophagy and apoptosis in peritoneal endometriosis in adolescents. Int. J. Mol. Sci. 2024; 25(8): 4238. https://dx.doi.org/10.3390/ijms25084238

9. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Эндометриоз. М.; 2024. 32 с.

10. Exacoustos C., Lazzeri L., Martire F.G., Russo C., Martone S., Centini G. et al. Ultrasound findings of adenomyosis in adolescents: type and grade of the disease. J. Minim. Invasive Gynecol. 2022; 29(2): 291‑299.e1. https://dx.doi.org/10.1016/j.jmig.2021.08.023

11. Gkrozou F., Vatopoulou A., Skentou C., Paschopoulos M. Diagnosis and treatment of adenomyosis with office hysteroscopy‑A narrative review of literature. Diagnostics (Basel). 2023; 13(13): 2182. https://dx.doi.org/10.3390/diagnostics13132182

12. Gordts S., Grimbizis G., Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil. Steril. 2018; 109(3): 380‑388.e1. https://dx.doi.org/10.1016/j.fertnstert.2018.01.006

13. Ebert A.D., Dong L., Merz M., Kirsch B., Francuski M., Böttcher B. et al. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: The VISanne study to assess safety in ADOlescents. J. Pediatr. Adolesc. Gynecol. 2017; 30(5): 560‑7. https://dx.doi.org/10.1016/j.jpag.2017.01.014

14. Maiorana A., Maranto M., Restivo V., Gerfo D.L., Minneci G., Mercurio A. et al. Evaluation of long‑term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis. Arch. Gynecol. Obstet. 2024; 309(2): 589‑97. https://dx.doi.org/10.1007/s00404‑023‑07271‑7.